These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease]. Moum B Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2565-7. PubMed ID: 14714043 [TBL] [Abstract][Full Text] [Related]
5. Conventional medical management of inflammatory bowel disease. Burger D; Travis S Gastroenterology; 2011 May; 140(6):1827-1837.e2. PubMed ID: 21530749 [TBL] [Abstract][Full Text] [Related]
6. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy. Nørgård BM Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578 [TBL] [Abstract][Full Text] [Related]
9. Management of inflammatory bowel disease. Botoman VA; Bonner GF; Botoman DA Am Fam Physician; 1998 Jan; 57(1):57-68, 71-2. PubMed ID: 9447214 [TBL] [Abstract][Full Text] [Related]
10. Crohn's Disease with Mesalazine Allergy that Was Difficult to Differentiate from Comorbid Ulcerative Colitis. Tsuboi R; Matsumoto S; Miyatani H; Mashima H Intern Med; 2019 Mar; 58(5):649-654. PubMed ID: 30333413 [TBL] [Abstract][Full Text] [Related]
11. Mesalazine-induced psoriasis in patients with inflammatory bowel diseases. Di Cesare A; Fidanza R; Riitano A; Fargnoli MC; Peris K Eur J Dermatol; 2011; 21(5):784-5. PubMed ID: 21697068 [No Abstract] [Full Text] [Related]
12. Pulmonary complications in patients with inflammatory bowel disease. Kuzela L; Vavrecka A; Prikazska M; Drugda B; Hronec J; Senkova A; Drugdova M; Oltman M; Novotna T; Brezina M; Kratky A; Kristufek P Hepatogastroenterology; 1999; 46(27):1714-9. PubMed ID: 10430329 [TBL] [Abstract][Full Text] [Related]
13. Mesalazine for the treatment of inflammatory bowel disease. Criscuoli V; Modesto I; Orlando A; Cottone M Expert Opin Pharmacother; 2013 Aug; 14(12):1669-78. PubMed ID: 23767798 [TBL] [Abstract][Full Text] [Related]
14. Encapsulated mesalamine granules (Apriso) for ulcerative colitis. Med Lett Drugs Ther; 2009 May; 51(1312):38-9. PubMed ID: 19448588 [TBL] [Abstract][Full Text] [Related]
15. Pancreatitis in inflammatory bowel diseases. Pitchumoni CS; Rubin A; Das K J Clin Gastroenterol; 2010 Apr; 44(4):246-53. PubMed ID: 20087199 [TBL] [Abstract][Full Text] [Related]
16. [Ulcerous colitis and Crohn's disease in members of one family: case description and review of literature]. Neĭman KP; Rumiantsev VG Eksp Klin Gastroenterol; 2006; (3):56-60. PubMed ID: 17203844 [No Abstract] [Full Text] [Related]
17. [Colorectal cancer in inflammatory bowel disease]. Henriksen M; Moum B Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2696-9. PubMed ID: 17952155 [TBL] [Abstract][Full Text] [Related]
19. [Consensus inflammatory intestinal diseases in children: ulcerative colitis and Crohn disease. Work Group Academic Medical Center, Amsterdam]. Büller HA; Maas SM Ned Tijdschr Geneeskd; 1996 Mar; 140(10):544-50. PubMed ID: 8628407 [TBL] [Abstract][Full Text] [Related]
20. Drug insight: aminosalicylates for the treatment of IBD. Nielsen OH; Munck LK Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]